There is no fulltext present in this item.

Find Full text  
Title: Effective oral hypomethylating drugs in intermediate-risk or high-risk myelodysplasia: a breakthrough?
Author(s): Witte, T.J. de
Publication year: 2019
Source: Lancet Haematology, vol. 6, iss. 4, (2019), pp. e170-e171
ISSN: 2352-3026
DOI: https://doi.org/10.1016/S2352-3026(19)30025-0
Publication type: Article / Letter to editor

Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/202794   https://hdl.handle.net/2066/202794

Display more details
Subject: Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences
Organization: Haematology
Tumorimmunology
Journal title:
Lancet Haematology
Volume: vol. 6
Issue: iss. 4
Page start: p. e170
Page end: p. e171

This item appears in the following Collection(s)

Browse

Statistics